Additionally, to clarify the molecular mechanism in metastatic inhibitory effects of propofol in breast cancer, Li et al20 reported that propofol reduced MMP expression via the suppression of nuclear factor‐kappa B (NF‐κB) pathways and inhibited the invasion and migration ability of cancer cells. The gene discussed is NFKB1; the disease is cancer.